ADHD is manageable and not indicative of a child’s lack of intelligence

Health Care, Heart Care Foundation of India, Medicine Comments Off

It is important to reinforce positive behavior in children with this condition and offer some understanding

New Delhi, 22nd April 2018: About 6% to 7% of children around the world are diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). It is one of the most common pediatric neurodevelopmental disorders associated with inattentiveness, hyperactivity, and impulsivity. Most teachers and parents do not recognize the signs of this condition, which can translate into a highly humiliating scenario for children.

ADHD is a disorder that makes it difficult to pay attention and control impulsive behaviours. The child may also be restless and almost constantly active. Although the symptoms begin in childhood, they can last way into adulthood as well.

Speaking about this, Padma Shri Awardee Dr K K Aggarwal, President Heart Care Foundation of India (HCFI),said, “The brain of a person with ADHD is generally 5% smaller than someone without ADHD, particularly regions involved in attention, impulse control, and stimulus integration. The other factors that play a role include imbalanced levels of the neurotransmitters norepinephrine and dopamine. Children with ADHD are extremely active and may also exhibit certain other behavioral problems. Provided this is addressed at the early stage, it can pose problems later in life. While there is no cure for ADHD, treatments revolve around reducing symptoms and improving functioning in such children. Some treatment options include medication, psychotherapy, education or training, or a combination of these.”

It must be noted that sugar doesn’t cause ADHD and neither does watching too much TV. It is also not a result of a poor home life, poor schools, or food allergies.

Adding further, Dr Aggarwal, who is also the Vice President of CMAAO, said, “It is possible to manage this condition in children through education, support, and letting them express their creativity. Although it is a challenge to stay organized with such children, some amount of prioritizing and managing time can go a long way. ADHD is not indicative of a child’s intelligence or capability. It is imperative that parents find out the strengths of such children and focus on them – this can result into positive outcomes.”

Some tips from HCFI.

  • Set clear boundaries about what kind of behavior is expected out of the child.
  • Reinforce positive behavior and praise or reward them if they adhere to it.
  • If the child seems to lose self-control, it is a good idea to intervene and distract them from the present situation.
  • Invite friends over so that the child can mingle.
  • Make sure the child gets quality sleep. It is better to avoid any strenuous activities near to bedtime.

The answer to high cost of drugs is Adopt a one drug-one price-one company policy

Health Care Comments Off

The recent comments of the Prime Minister on doctors in his visit to the UK have been widely criticized among the fraternity. Yes, he should not have spoken so.

But, let’s go back to his main allegation that doctors don’t write cheaper medicines.

There are two types of drugs in India: patented and non-patented. It is the non-patented drugs, which are called generic drugs. The only way to differentiate between the two is to give the drug a name, either a brand name or the name of the pharmaceutical company.

Unfortunately, the current policy in the country allows the same generic to be sold under three names: Generic-Generic, Trade Generic and Branded Generic.

Branded Generics are full-fledged branded drugs i.e. they are marketed under a brand name. Trade Generic drugs are high margin, non promoted brand generic drugs. The Jan Aushadhi drugs are generic-generic drugs.

Call them by any name, Generic-Generic, Trade Generic or Branded Generic, their quality is the same, what is different between them is their cost.

It is the government, which is allowing the one company to market a generic drug under three names (generic-generic, trade generic and branded-generic) and also at differential prices.

So, instead of criticizing doctors, the government ought to allow non-patented drugs at one price (one drug one company one price policy).

We respect the sentiments of our Prime Minister; he represents the collective consciousness of all citizens of the country.

But, I would like to say to him, respected Prime Minister Ji, if you want to reduce the cost of medicines, the solution is simple – “adopt a one drug-one price-one company policy”. Also request all doctors to choose NLEM drugs unless there are reasons not to write them.

Dr KK Aggarwal

Padma Shri AwardeeVice President CMAAOGroup Editor-in-Chief IJCP Publications

President Heart Care Foundation of India

Immediate Past National President IMA